Surgical mitral valve repair produces exceptional long-term survival, durable relief from mitral regurgitation, and physiological valve performance. Percutaneous mitral valve repair might prohibit subsequent surgical reconstruction. This finding has important implications, including for patient consent and clinical trial design. The objectives of mitral valve intervention must focus on life expectancy and long-term valve function.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Feldman, T. et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J. Am. Coll. Cardiol. 66, 2844–2854 (2015).
Chikwe, J. et al. Mitral surgery after transcatheter edge-to-edge repair: Society of Thoracic Surgeons database analysis. J. Am. Coll. Cardiol. https://doi.org/10.1016/j.jacc.2021.04.062 (2021).
Ibrahim, M. E., Bavaria, J. E. & El-Hamamsy, I. A biological approach to aortic valve disease: durability and survival. Nat. Rev. Cardiol. 17, 754–756 (2020).
Lazam, S. et al. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry. Circulation 135, 410–422 (2017).
Levine, R. A. et al. Mitral valve disease—morphology and mechanisms. Nat. Rev. Cardiol. 12, 689–710 (2015).
Sonnenblick, E. H., Napolitano, L. M., Daggett, W. M. & Cooper, T. An intrinsic neuromuscular basis for mitral valve motion in the dog. Circ. Res. 21, 9–15 (1967).
D’Agostino, R. S. et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2019 update on outcomes and quality. Ann. Thorac. Surg. 107, 24–32 (2019).
Otto, C. M. et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143, e35–e71 (2021).
De Bonis, M. et al. Long-term results (≤18 years) of the edge-to-edge mitral valve repair without annuloplasty in degenerative mitral regurgitation: implications for the percutaneous approach. Circulation 130, S19–S24 (2014).
Chikwe, J. Ask the Expert Session: Management of degenerative mitral regurgitation in intermediate risk patients. Presented at the Society of Throacic Surgeons Annual Meeting 2021.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ibrahim, M., Hargrove, W.C. Imperatives in mitral valve interventions: long-term survival, valve durability and valve performance. Nat Rev Cardiol 18, 545–546 (2021). https://doi.org/10.1038/s41569-021-00590-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-021-00590-9